A multidimensional examination of resilience in multiple sclerosis.
Rehabilitation Psychology · 2026
DOI: 10.1037/rep0000693 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Rehabilitation Psychology, 2026. Verfasst von Jennifer G Pearlstein und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological and Brain Sciences, Washington University in St. Louis. Hauptthemen laut MEDLINE: Multiple Sclerosis, Resilience, Psychological. Gefördert von: University of Washington, National Institute on Disability, Independent Living and Research, National Institutes of Health; National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychological and Brain Sciences, Washington University in St. Louis.
- Department of Clinical Psychology, Seattle Pacific University.
- Berkeley School of Education, University of California, Berkeley.
- Department of Rehabilitation Medicine, University of Washington.
ORCID-Profile: Jennifer G Pearlstein, Natalie A Snodgrass, Mercedes A Zapata, Dawn M Ehde
Förderung
- University of Washington
- National Institute on Disability, Independent Living and Research
- National Institutes of Health; National Center for Advancing Translational Sciences
- National Institutes of Health
Zitieren
APA
Pearlstein, J. G., Snodgrass, N. A., Zapata, M. A., & Ehde, D. M. (2026). A multidimensional examination of resilience in multiple sclerosis. Rehabilitation Psychology. https://doi.org/10.1037/rep0000693
Vancouver
Pearlstein JG, Snodgrass NA, Zapata MA, Ehde DM. A multidimensional examination of resilience in multiple sclerosis. Rehabilitation Psychology. 2026. doi:10.1037/rep0000693
BibTeX
@article{Pearlstein2026,
author = {Pearlstein, Jennifer G and Snodgrass, Natalie A and Zapata, Mercedes A and Ehde, Dawn M},
title = {A multidimensional examination of resilience in multiple sclerosis},
journal = {Rehabilitation Psychology},
year = {2026},
doi = {10.1037/rep0000693}
}
EUVIMED